Asia
Tonghua Golden-Horse Pharmaceutical's Attributable Profit Slides 39% in 2025
Tonghua Golden-Horse Pharmaceutical's (SHE:000766) attributable profit fell 39% to 34.3 million yuan in 2025 from 56.4 million yuan in 2024, according to a Wednesday filing with the Shenzhen bourse.Earnings per share at the drug company decreased 33% to 0.04 yuan from 0.06 yuan in the previous year.Operating income declined 12% year over year to 1.17 billion yuan from 1.32 billion yuan.
SHE:000766
